“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”
“The RNA team helped us from inception through our IPO and beyond. They are one of the top firms that I know of at the intersection of valuation, biotech and finance. I’d recommend them for my life science venture-backed company colleagues.”
“RNA is my go to firm for diligence, modeling and valuation projects. Responsive…check, reliable…check, understand my investments and companies…check.”
“The RNA team has helped us with tax and financial reporting-oriented valuation work. Its nice to work with a firm that not only understands the intricacies of reporting requirements but actually understands the drug development business.”
Enter your email address below to receive updates from RNA Advisors.